A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant HIV.

Understand the significance of proteo-transcriptomics in identifying vulnerabilities in Candida auris and addressing drug ...

For patients with advanced melanoma without BRAF mutation who no longer respond to immune checkpoint inhibitors, treatment ...

Antibiotic resistance is one of the world's leading causes of death, claiming the lives of more people than HIV / AIDS or ...

People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...

With resistance spreading and new antibiotics arriving slowly, targets highlighted by viruses could keep future infections ...

Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the ...

Newly developed 'nanoagents' can carry drugs straight to the heart of an infection - providing localised therapy with minimal amount of drug and reducing the risks of antibiotic resistance.

A hard-to-treat drug-resistant fungus known as Candida auris is spreading in intensive care units (ICUs) in Dhaka, according ...

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

BV100 is a novel intravenous formulation of rifabutin based on the newly identified mode of action for the active uptake of rifabutin into the Acinetobacter baumannii-calcoaceticus complex. BV100 is ...